Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-22.79%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) Fails to deliver data
Key failure to deliver metrics for Lineage Cell Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.11 M
- Last 3 months FTD volume: $0.23 M
- Last year FTD volume: $1.73 M
Failures to deliver for Lineage Cell Therapeutics (LCTX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Lineage Cell Therapeutics (LCTX) - since 2019
Volume in USD (price x number of shares), data since 2019Lineage Cell Therapeutics (LCTX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.23 M | -87.45% |
| 2023 | $1.9 M | -54.82% |
| 2022 | $4.21 M | -66.55% |
| 2021 | $12.59 M | 159.36% |
| 2020 | $4.85 M | 399.21% |
| 2019 | $0.97 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.25 M | $6.85 M | 🇺🇸 USA |